Resolution Therapeutics doses first patient in EMERALD study of RTX001
Trial explores regenerative macrophage therapy for liver disease Trial explores regenerative macrophage therapy for liver disease
Previous Post
Heart failure treatment: USFDA approves Caplin Steriles Milrinone Lactate in 5% Dextrose Injection, Infusion bags
Next Post
HC stays NMC ban on Karnataka's Medical College over bribery allegations, restores 200 MBBS seats
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago